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THE influence of anti-allergic drugs, epinastine hydro-
chloride (EP) and disodium cromoglycate (DSCG), on
the  co-stimulatory  molecule  expression  was  exam-
ined using in vitro cell culture technique. Spleen cells
obtained from BALB/c mice 10 days after immuniza-
tion  with  haemocyanin  absorbed  to  aluminium
hydroxide  were  cultured  in  the  presence  of  100.0
m g/ml  haemocyanin  and  various  concentrations  of
the agents. Low concentrations (<1.5 ´ 10–4 M) of EP
and DSCG did not influence spleen cell blastic activity
induced  by  antigenic  stimulation,  whereas  these
agents  caused  significant  inhibition  of  spleen  cell
activation when 2 ´ 10–4 M of the agents were added to
cell cultures. EP and DSCG also did not affect blastic
activity  of  sensitized  splenic  T  cells  by  anti-CD3
monoclonal  antibody  stimulation  even  when  these
cells were cultured in the presence of 2 ´ 10–4 M of the
agents.  We  next  examined  the  influence  of  EP  and
DSCG on the expression of co-stimulatory molecules
on spleen cells in response to antigenic stimulation.
Sensitized spleen cells were cultured in the presence
of  2  ´ 10–4M  of  the  agents  and  the  expression  of
molecules  were  examined  by  flow  cytometer  24h
later. EP and DSCG suppressed the expression of co-
stimulatory molecules, CD40 and CD80, but not CD86,
on splenic B cells which were enhanced by antigenic
stimulation in vitro.
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Introduction
Current  theories  on  the  pathogenesis  of  allergic
diseases such as asthma, atopic dermatitis and allergic
rhinitis, clearly show that inflammatory responses are
important  determinants  of  the  diseases.1 Several
inflammatory  cells  including  eosinophils  and  mast
cells,  and  IgE  antibody  have  been  postulated  to
participate  in  the  inflammatory  responses  to  anti-
genic stimulation.2,3 It is generally accepted that the
central cells in these responses are the T lymphocytes:
T  lymphocytes,  especially  helper  T  lymphocytes,
upon  contact  with  allergens,  activate  and  release
several types of lymphokines that control the estab-
lishment and regulation of the inflammatory respon-
ses that underly many allergic diseases.
Antigen-specific T cell activation requires triggering
via  the  antigen-specific  T  cell  receptor  and  a  co-
stimulatory  signal  usually  provided  by  antigen  pre-
senting  cells  (APC)  including  B  cells  and  macro-
phages.4–7 Interaction of T cells with antigen in the
absence of sufficient co-stimulation can result in T cell
unresponsiveness–termed anergy.7,8 A number of APC
surface determinants have been shown to be capable
of  providing  T  cell  co-stimulation.  Activated  APC
express CD80, which co-stimulates T cells via binding
to the counter receptor CD28.4,7 CD86,  which also
binds  to  CD28,  is  constitutively  expressed  on  pro-
fessional  and  non-professional  APC  earlier  than
CD80.4,7 The  interaction  between  CD40  molecules
and  its  ligand,  CD40L,  on  T  cells  has  also  been
identified  as  an  important  co-stimulatory  signal
required  for  switch  recombination  to  IgE
synthesis.9,10
A number of anti-allergic drugs such as azelastine,
epinastine hydrochloride (EP), and disodium cromo-
glycate  (DSCG)  have  been  developed  and  are  used
clinically  in  the  treatment  and  the  management  of
allergic diseases. The mechanisms of action of these
agents on allergic diseases are generally believed to be
owing, in part, to their inhibitory action on chemical
mediator release from effector cells such as eosino-
phils and mast cells.11,12Although these agents are also
reported to display antagonistic effects on chemical
mediators,13,14 there  is  little  information  about  the
influence  of  anti-allergic  agents  on  co-stimulatory
molecule  expression.  Therefore,  in  this  study  we
examined whether anti-allergic agents could modulate
the expression of co-stimulatory molecules on lympho-
cytes by an in vitro cell culture technique.
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Mice
Specific pathogen free, male BALB/c mice, 5 weeks of
age  were  purchased  from  Charles  River  Japan  Inc.
(Atsugi, Japan). Each experimental and control group
consisted of five mice. Animal care and handling were
in accordance with the principles stated in the Guide
for the  Care  and  Use of  Laboratory Animals  (Prime
Minister’s  Office  of  Japan,  Publication  No.  85–23,
1985). The experimental protocols of this study were
approved by the Animal Care and Use Committee of
Showa University.
Immunization
Mice were immunized by intraperitoneal injection of
8.0 m g/ml  haemocyanin  (Sigma  Chemical  Co.,  St
Louis, MO) absorbed to 4.0 mg aluminium hydroxide
(Wako  Chemical  Co.,  Ltd,  Osaka,  Japan)  in  0.5ml
saline.
Agents
EP  was  kindly  supplied  by  Boehringer  Ingelhaim
(Ingelhaim, Germany) as a water soluble pure pow-
der. The powder was dissolved in saline at a concen-
tration of 5 ´ 10–2 M. This solution was then filtered
through  a  0.22 m m filter  (Nihon  Millipore  Co., Ltd,
Yonezawa, Japan) and stored as a stock solution at 4°C
until  used.  All  dilutions  used  in  this  study  were
prepared  from  this  stock  solution  by  dilution  with
RPMI-1640 medium (Wako Chemical) supplemented
with  10%  foetal  calf serum (Sigma  chemical;  RPMI-
FCS). DSCG was purchased from Fujisawa-Fison Co.,
Osaka,  Japan  as  a  solution  in  distilled  water. This
solution contained 5.0 M DSCG. All dilutions used in
this study were prepared from this solution.
Cell preparation
Spleen was removed from five individual mice 10 days
after  the  immunization. These  organs  were  pressed
through  60  gauge  steel sieves into  saline. The cells
were washed once with saline and then treated with
Tris-buffered  ammonium  chloride  (17 mM Tris-HCl–
0.73%  NH4Cl,  pH  7.6)  for  5min  to  lyse  red  blood
cells. After passing through 200 gauge steel sieves, the
residual cells were washed three times, resuspended
in saline at a concentration  of 1 ´ 106 cells/ml and
used for splenocytes. In the case of experiments using
purified T cells, T cells were separated from spleno-
cytes using a magnetic cell separator (Milteny Biotec
GmbH,  Bergisch  Gladbach,  Germany)  according  to
the  manufacturer’s  instructions.  Splenocytes  were
labeled with anti-mouse CD19 monoclonal antibody
(mAb)-coated  magnetic  microbeads  (Milteny  Biotec
GmbH). These cells were then applied to the column
placed in the separator and the column was washed
with  PBS.  The  entire  effluated  cells  were  washed
twice and resuspended in saline at a concentration of
1 ´ 106 cells/ml. The purity of the cells was checked
by  incubating  separated  cells  with  fluorescein  iso-
thiocyanate  (FITC)-conjugatedmAb  to  CD90  (Phar-
Mingen,  San  Diego,  CA).  Fluorescence  microscopic
examination revealed that more than 98% of the cells
were  CD90  positive,  and  these  cells  were  used  as
splenic T cells.
Cell proliferation assay
Splenocytes  prepared  as  above  were  washed  once
and resuspended in RPMI-1640 medium (Wako Chem-
ical) supplemented with 10% foetal calf serum (Sigma
Chemical;  RPMI-FCS)  at  a  concentration  of 1 ´ 106
cells/ml.  To  examine  blastic  activity  of  the  cells,
100 m l of cell suspension was introduced into each
well  of  96-well  flat-bottomed  culture  plates  (Nunc,
Denmark). Various concentrations of the anti-allergic
agents, EP and DSCG, and 100.0 m g/ml haemocyanin
were added in another 100 m l to give a total volume of
200 m l. These mixtures were then incubated at 37°C
in  a humidified atmosphere of 5% CO2 in  air. After
40 h culture, 37 kBr of 3H-thymidine (specific activity
740 GBq/mmol, New England Nuclear, Boston, MA,
USA)  was  added  to  each  well,  and  the  plate  was
maintained for another 8 h. Cells were collected on
glass fiber filters for liquid scintillation counting using
a  Packard Tricarb  liquid  scintillation  spectorometer.
The  results  were  expressed  as  mean  counts  per
minute (cpm)±SD of triplicate cultures. For examina-
tion  of  the  proliferative response of  splenocytes  to
anti-CD3  stimulation,  100 m l  of  PBS  containing
20.0 m g/ml ofmAb to mouse CD3« (Genzyme, Min-
neapolis, MN, USA) was introduced into each well of
96-well flat-bottomed culture plates (Nunc, Denmark)
in triplicate and incubated overnight at 4°C.15 Before
use, the plates were washed once with 200 m l PBS.
Splenic  T  cells  prepared  as  above  were  cultured
in mAb-coated plates that contained various concen-
trations of agents at 2 ´ 105 cells in a final volume of
200 m l for 48 h. The cell proliferation was assessed in
a similar manner. For examination of the influence of
the  agents  on  co-stimulatory  molecule  expressions,
0.5 ml of  the  cell  suspensions  (5 ´ 105 cells)  were
dispensed  into  24-well  flat-bottomed  culture  plates
(NUNC) that contained 0.5 ml of various concentra-
tions  of  the  agents  and  100.0 m g/ml  antigen.  The
plates were maintained for 24 h at 37°C in a humid-
ified atmosphere of 5% CO2 in air. The cells were then
collected by centrifugation, washed twice with saline,
resuspended at a concentration of 1 ´ 105 cells/ml,
and stored on ice until processed.
Flow cytometry
The mAbs used for flow cytometry were anti-mouse
CD16/32 mAb,  FITC-conjugated  anti-mouse  CD40,
CD80  and  CD86 mAbs. They  were  purchased  from
J. Ito et al.
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molecules  with  specific  antibodies,  the  purified
cultured  B  cells  (1  ´ 106 cells)  were  treated  with
1.0 m g of anti-mouse CD16/32 mAb for 5 min at 4°C to
block non-specific Fc receptor mediated binding of
antibodies. Pre-treated cells were  then stained with
either FITC-conjugated mAb to CD40, CD80 or CD86
for  25min  at  25°C. After  washing  once,  cells  were
suspended  in  saline,  and  assayed  for  fluorescence
intensity  on  cells  using  Flow  cytometer  (Becton
Dickinson, Mountain View, CA, USA).
Statistical analysis
The  statistical  significance  of  the  difference  in  the
mean  value  between  two groups  was examined  by
the Mann–Whitney U test.
Results
Influence of EP on proliferative response of
lymphocytes in vitro
The first set of experiments was designed to examine
the  influence  of  EP  on  proliferative  response  of
spleen  cells  induced  by  in  vitro stimulation  with
antigens. Spleen  cells  prepared  from five  individual
mice immunized with haemocyanin were cultured in
vitro in  the  presence  of  100.0 m g/ml  haemocyanin
and various concentrations of EP for 48 h. As shown in
Fig. 1A, low doses of EP (10–4 M and 1.5 ´ 10–4 M) did
not affect the proliferative activities of spleen cells in
response to haemocyanin stimulation in vitro. How-
ever, a  statistically significant  inhibition of cell  pro-
liferation was observed when the cells were cultured
in the presence of 2 ´ 10–4 M of the agent. Further
experiments  were  carried  out  to  examine  whether
the suppressive activity of EP on antigen-induced cell
proliferation was also observed in cells stimulated by
anti-CD3 mAb.  To  do  this,  splenic  T  cells  from
haemocyanin-immunized  mice  were  cultured  with
solid phase ofmAb in the presence of various doses of
EP for 48 h. As shown in Fig. 1B, EP did not interfere
with the proliferative response of sensitized splenic T
cells  even  when  the  cells  were  cultured  with  2  ´
10–4 M EP.
Influence of EP on co-stimulatory molecule
expression
This study was carried out to examine the influence
of  EP  on  co-stimulatory  molecule  expressions  on
splenocytes.  Spleen  cells  prepared  from  haemocya-
nin-immunized  mice  were  cultured  in  vitro in  the
presence of 100.0 m g/ml haemocyanin and 2 ´ 10–4 M
of EP for 24 h. The cultured cells were stained with
FITC-labeled mAbs  against  co-stimulatory  molecules
and were analyzed by flow cytometry for the expres-
sion of CD40, CD80 and CD86 on their cell surface. As
shown in Fig. 2, addition of EP into cell cultures at a
dose  of  2  ´ 10–4 M  significantly  suppressed  CD40
expression on the cells, which were enhanced by in
vitro stimulation  with  haemocyanin.  EP  also  sup-
presses  the  ability  of  the  cells  to  express  CD80
molecules on their cell surface induced by antigenic
stimulation in vitro (Fig. 2).
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FIG. 1. Influence of epinastine hydrochloride (EP) on in vitro proliferative response of splenic lymphocytes. BALB/c mice were
immunized by intraperitoneal injection with 8.0 m g haemocyanin absorbed to 4.0mg aluminium hydroxide in a volume of
0.5ml.  Spleen  cells  (1  ´ 10
5 cells/0.1ml)  prepared  from  mice  10  days  later  were  cultured  in  the  presence  of  various
concentrations of EP for 48h, which were stimulated with specific antigen (A). Splenic T cells (2 ´ 10
5 cells/0.1ml) were also
cultured with immobilized anti-CD3« monoclonal antibody in the presence of various concentrations of EP for 48h (B). These
cells were pulsed with 1.0 m Ci 
3H-thymidine for the last 8h of culture. The results were expressed as the mean±SD of five
individual mice. NC: non-stimulated control. *P<0.01, significantly different as compared with no agent.Influence of DSCG on the response of
splenocytes to antigenic stimulation
Since  many  kinds  of  anti-allergic  agents  are  used
clinically, the results described above leave open the
questions of whether these anti-allergic agents have
similar suppressive effects on cell functions to those
observed in EP. Therefore, we chose DSCG, one of the
best-known  anti-allergic  agents,  and  examined
whether  it  also  has  inhibitory  effects  on  cell  func-
tions, such as proliferation and co-stimulatory mole-
cule expression, induced by in vitro antigenic stim-
ulation.  As  in  the  case  of  EP,  DSCG  exerted
suppressive effects on antigen-induced, but not anti-
CD3-mediated, proliferative responses of splenocytes
(Fig. 3A and B), when the cells were cultured in the
presence  of  2  ´ 10–4 M  DSCG.  Flow  cytometric
analysis  also  revealed  the  suppressive  activity  of
DSCG on the expression of co-stimulatory molecules,
CD40  and CD80,  which are enhanced  by antigenic
stimulation in vitro (Fig. 4)
Discussion
Asthma  and  atopic  allergy  are  characterized  by
infiltration  of  the  bronchial  and  nasal  mucosa  with
large numbers of activated eosinophils and mast cells
and  the  presence  of  elevated  concentrations  of
chemical mediators as well as granule-derived basic
proteins.2,3The acute symptoms of allergy and asthma
J. Ito et al.
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FIG. 2. Influence of epinastine hydrochloride (EP) on co-stimulatory molecule expression on spleen cells induced by antigenic
stimulation. Spleen cells (1 ´ 10
6 cells/ml) prepared from five individual mice 10 days after immunization were cultured with
or without 2 ´ 10
–4 M EP for 24h. The expression was analyzed by flow cytometer: (____) cultured without antigen; (_ _ _ _)
cultured with antigen; (_ · _ · _) cultured with antigen and EP.
FIG. 3. Influence of disodium cromoglycate (DSCG) on proliferative response of lymphocytes in vitro. BALB/c mice were
immunized by intraperitoneal injection with 8.0 m g haemocyanin absorbed to 4.0mg aluminium hydroxide in a volume of
0.5ml.  Spleen  cells  (1  ´ 10
5 cells/0.1ml)  prepared  from  mice  10  days  later  were  cultured  in  the  presence  of  various
concentrations of DSCG for 48h, which were stimulated with specific antigen (A). Splenic T cells were also cultured with
immorbilized anti-CD3« monoclonal antibody in the presence of various concentrations of DSCG for 48h (B). These cells were
pulsed with 1.0 m Ci 
3H-thymidine for the last 8h of culture. The results were expressed as the mean±SD of five individual mice.
NC: non-stimulated control. *P<0.05, significantly different as compared with no agent.such  as  sneezing,  bronchospasm  and  hives  are
believed to be largely the results of mediator release
from  mast  cells  and  basophils,2,3 whereas  chronic
symptoms, the result of allergic inflammation, can be
explained on the basis of eosinophil-mediated tissue
damage.2,3,16 Based  on  these  established  ideas,  the
treatment  of  allergic  diseases  still  focuses  on  the
inhibition  of  mediator  release  or  on  blocking  the
binding  of  soluble  mediators  to  their  receptors.
However,  additional  evidence  clearly  shows  that T
cells  play  a  central  role  in  the  driving  and  main-
tenance  of  all  these  processes  by  elaboration  of
several types of cytokines.2,3,16,17 There is now also
circumstantial  evidence  that  the  CD28/B7  co-stim-
ulatory is critical in T cell activation, proliferation and
cytokine  production.4 –7,18 Yet  the  action  of  anti-
allergic  agents  on  the  co-stimulatory  pathway  is
poorly understood. To examine the influence of anti-
allergic agents in the co-stimulatory pathway, it was
first tested on the response of lymphocytes to in vitro
antigenic  stimulation  by  examining  DNA  synthetic
activity. The present results (Figs 1A and 3A) clearly
show the inhibitory effect of EP and DSCG on DNA
synthetic activity (proliferation) of sensitized spleen
cells in response to in vitro stimulation with specific
antigen.  However,  EP  and  DSCG  could  not  inhibit
DNA synthetic activity of sensitized splenic T cells by
anti-CD3 stimulation (Figs 1B and 3B), suggesting that
inhibition of the proliferative responses of sensitized
spleen cells by specific antigen is not due to cytotoxic
action of the agents to splenic T cells. It is reported
that  anti-allergic  agents  did  not  interfere  with  the
ability  of  APC  to  process  antigens.19 The  present
results,  therefore,  may  suggest  that  EP  and  DSCG
inhibit proliferation of sensitized spleen cells induced
by antigenic stimulation through the suppression of
signal transmission required for DNA synthesis.
T and B cells play a critical role in the pathogenesis
of allergic diseases. Activation of resting lymphocytes
requires the engagement of the T cell receptor with a
peptide/MHC  as  well  as  the  engagement  of  appro-
priate co-stimulatory molecules.4–7 In particular, sig-
nals  through  the  CD28/CTLA-4  co-stimulatory  path-
way  are  essential  for  primary  activation  of  antigen
specific T cells.20 It is reported that CTLA-4 immuno-
globuline  fusion  protein  (CTLA-4Ig),  a  blocker  of
CD28/B7  co-stimulation,  could  block  allergen-
induced  proliferation  and  cytokine  production  of
peripheral  blood  mononuclear  cells  from  atopic
donors, when the cells were cultured in vitro in the
presence  of  CTLA-4Ig.18 In  addition  to  the  CD28/
CTLA-4 co-stimulatory signals, CD40 ligand (CD40L)
was  also  reported to  play an  important  role in  the
interaction between helper T cells and APC.21,22 The
CD40L–CD40 interaction can upregulate the expres-
sion of B7 molecules on APC, which are essential for
helper T  cell  activation,  and  enhances T  cell  pro-
liferative  responses.23,24 Therefore,  we  examined
whether EP and DSCG suppress the expression of co-
stimulatory  molecules,  CD40,  CD80  and  CD86,  on
sensitized B lymphocytes, induced by in vitro stimula-
tion with specific antigen and resulted in inhibition of
in  vitro T  cell  proliferative  responses. The  present
results clearly show that EP and DSCG could suppress
the expression of co-stimulatory molecules, CD40 and
CD80 but not CD86, on sensitized B cells which were
enhanced by in vitro stimulation with antigen (Figs. 2
and 4). Prophylactic treatment  of the patients with
anti-allergic  agents  is  recognized  to  prevent  the
development  of  the  diseases  by  inhibition  of  IgE
hyper-production,9,25 but  the  mechanisms  are  not
well defined. Induction of IgE synthesis from B cells
requires  two  distinct  signals.  The  first  signal  is
delivered by IL-4 and the second is provided by T–B
cell  contact  through  the  ligation  of  CD40  and
CD40L.9,10 Together with the present results, it may
be speculated that anti-allergic agents exerted inhibi-
tory  effects  on  the  development  of  the  diseases
through the suppression of CD40 expression, when
agents were administered prophylactically.
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FIG. 4. Influence of disodium cromoglycate (DSCG) on co-stimulatory molecule expression on spleen cells induced by antigenic
stimulation. Spleen cells (1 ´ 10
6 cells/ml) prepared from five individual mice 10 days after immunization were cultured with
or without 2 ´ 10
–4 M of DSCG for 24h. The expression was analyzed by flow cytometer: (____) cultured without antigen; (_ _
_ _) cultured with antigen; (_ · _ · _) cultured with antigen and DSCG.Recent  reports have examined the co-stimulatory
dependence of allergen-specific  human T  cells,  and
the role of these CD28 and CD80  in animal models
of allergic inflammation. De Boer et al. showed that
CD80 could act as a co-stimulator molecule for Th2
type  cytokine,  IL-4  and  IL-5,  productions  from
human  peripheral  blood T  cells  activated  by  mAb
directed at T cell receptor.26 It is also reported that
CD80  blockade  prevents  antigen  specific  prolifer-
ative  responses  of  T  cells  from  atopic  dermatitis
against  Dermatophagoides  farinae.27 In  murine
models for inflammatory diseases, blockade of CD80
is reported to ameliorate the diseases.28 With regard
to  the  influence  of  CD80  on  effector  cell  (e.g.
eosinophil)  functions,  Tsuyuki  et  al.  showed  that
intranasal administration of anti-CD80 mAb inhibited
eosinophil accumulation in  lungs and airway tracts,
but was less effective in inhibiting peripheral blood
eosinophilia induced by aerosol provocation of aller-
gen.29 CD80  blockade was also reported to be able
to  prevent  eosinophil  influx  into  lungs  and  airway
tracts when the mice were injected with anti-CD80
mAb  during  the  aerosol  challenge.30 These  sup-
pressive  effects  of  CD80  may  be  owing  to  its
inhibitory action on adhesion molecule expressions,
since CD80 blockade is reported to prevent acquisi-
tion  by  lymphocytes  including  eosinophils  of  the
adhesion  molecules  involved  in  recirculation
through  tissue,  and  upregulation  of  their  ligands
such  as  ICAM-1  on  endothelium.31 Judging  from
these reports, the  present  results  showing the sup-
pressive  effect  of  anti-allergic  agents  on  CD80,  but
not  CD86,  expression  suggest  that  anti-allergic
agents, especially EP and DSCG, are effective in the
prevention  of  allergic  inflammatory  responses  in
lungs and airway tracts.
Pharmacological  studies  revealed  that  EP  and
DSCG  prevent  calcium  cation  influx  into  immune
cells,14,32 resulting  in  reduced  permeability  of  cell
membrane and  inhibition  of  expression of  proteins
synthesized  in  the  cytosol.  It  is  also  reported  that
anti-allergic agents including EP  and DSCG  increase
intracellular  cyclic  adenosine  monophosphate
(cAMP)  level  by  inhibiting  adenylate  cyclase  activ-
ity.14,33 Elevation  of  intracellular  cAMP  level  elabo-
rates  an  important  down-regulatory  signal  in  the
release  of  proteins  synthesized  in  the  cytosol.34,35
From these reports, it is possible that EP and DSCG
cause  prevention  of  the  accumulation  of  calcium
cation  in  the  cytosol  and  enhance  intracellular
cAMP  level  resulting  in  inhibition  of  CD  molecule
expressions.  Although  the  present  data  add  novel
information  about  the  beneficial  effects  of  anti-
allergic  agents  on  the  diseases,  the  precise  mecha-
nism(s)  by  which  the  agents  inhibit  co-stimulatory
molecule  expressions  is  not  yet  fully  understood.
Further  experiments  are  needed  to  clarify  this
point.
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